Matches in Wikidata for { <http://www.wikidata.org/entity/Q37640588> ?p ?o ?g. }
Showing items 1 to 94 of
94
with 100 items per page.
- Q37640588 description "article científic" @default.
- Q37640588 description "article scientifique" @default.
- Q37640588 description "articolo scientifico" @default.
- Q37640588 description "artigo científico" @default.
- Q37640588 description "artículu científicu espublizáu en 2013" @default.
- Q37640588 description "bilimsel makale" @default.
- Q37640588 description "scientific article published on July 2013" @default.
- Q37640588 description "vedecký článok" @default.
- Q37640588 description "vetenskaplig artikel" @default.
- Q37640588 description "videnskabelig artikel" @default.
- Q37640588 description "vědecký článek" @default.
- Q37640588 description "wetenschappelijk artikel" @default.
- Q37640588 description "wissenschaftlicher Artikel" @default.
- Q37640588 description "наукова стаття, опублікована в липні 2013" @default.
- Q37640588 description "научни чланак" @default.
- Q37640588 description "مقالة علمية نشرت في يوليو 2013" @default.
- Q37640588 name "In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival." @default.
- Q37640588 name "In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival." @default.
- Q37640588 name "In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival." @default.
- Q37640588 type Item @default.
- Q37640588 label "In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival." @default.
- Q37640588 label "In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival." @default.
- Q37640588 label "In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival." @default.
- Q37640588 prefLabel "In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival." @default.
- Q37640588 prefLabel "In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival." @default.
- Q37640588 prefLabel "In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival." @default.
- Q37640588 P1433 Q37640588-6D1AC9F4-EA01-4E8B-A03A-61D53DCDB238 @default.
- Q37640588 P1476 Q37640588-7003647C-4EC5-4A07-A903-83FE8022BA13 @default.
- Q37640588 P2093 Q37640588-003A1004-302F-4382-A495-304E98A83AE7 @default.
- Q37640588 P2093 Q37640588-491E4163-84EC-45F2-AEBF-14D095779649 @default.
- Q37640588 P2093 Q37640588-794E7D01-359E-41BC-A5D9-34A12EBF959A @default.
- Q37640588 P2093 Q37640588-865B013A-BA02-42CD-91A6-984ACFA64741 @default.
- Q37640588 P2093 Q37640588-BAB272F4-46EE-4C70-8173-D5AEAC10F721 @default.
- Q37640588 P2093 Q37640588-BE5AAEF4-5823-4F9B-84CD-84E74B21C622 @default.
- Q37640588 P2093 Q37640588-EFCD376F-759E-4B0E-A8F2-C629CB4EF1DE @default.
- Q37640588 P275 Q37640588-5238A4AE-FFC8-4CEF-B3C9-DBE819197C9A @default.
- Q37640588 P2860 Q37640588-0B4D3373-4B7F-4666-A03A-8920A1F2699A @default.
- Q37640588 P2860 Q37640588-159550A6-6AB1-4B02-962E-DCBB4E53A935 @default.
- Q37640588 P2860 Q37640588-2214DF29-BD01-49FD-92D3-EADBE8B4868A @default.
- Q37640588 P2860 Q37640588-2AA0D8C4-8658-4E08-B347-EC644B2AFA91 @default.
- Q37640588 P2860 Q37640588-3D0E0579-8693-442D-ABDA-315C012A58EF @default.
- Q37640588 P2860 Q37640588-4F49FBD8-E0E2-4AFE-A334-01B647EA6A4C @default.
- Q37640588 P2860 Q37640588-4FB5B517-7CF4-4065-A50F-D89105F635E7 @default.
- Q37640588 P2860 Q37640588-5A252F4D-1B3D-4843-8FDA-5E4A57ADE883 @default.
- Q37640588 P2860 Q37640588-B059FEA5-AA67-4B62-8629-E38F6EBFC6B3 @default.
- Q37640588 P2860 Q37640588-CFCEBC75-5184-4541-B83D-02A80F8D807E @default.
- Q37640588 P2860 Q37640588-D98558C0-CBA7-4AFA-9275-ADC384D58CFE @default.
- Q37640588 P2860 Q37640588-DE67A49C-5B60-490B-B131-D7042147B694 @default.
- Q37640588 P304 Q37640588-FDCC10D5-6D9F-45F6-8AE1-73E4E1CEE301 @default.
- Q37640588 P31 Q37640588-0A92786D-F98D-4D30-80A5-6EEDE45F8AB9 @default.
- Q37640588 P356 Q37640588-FB664590-5365-4248-9EDD-96F5DD91C505 @default.
- Q37640588 P407 Q37640588-9AA54CF8-F43A-47CB-A9FD-72D373D1506B @default.
- Q37640588 P433 Q37640588-063B17E4-BEA7-453F-8D71-B88E33058DE8 @default.
- Q37640588 P478 Q37640588-BE6784E0-39AD-4BF0-9BB7-EBA6DC3ED977 @default.
- Q37640588 P50 Q37640588-EFEED77C-C8F6-43C7-BF9C-27A5F95148AA @default.
- Q37640588 P577 Q37640588-48A68F3A-73A9-4FBE-A7C5-3C5E05CBEBAC @default.
- Q37640588 P6216 Q37640588-DA0933C2-0E2F-4B91-B409-493C1FB7BB13 @default.
- Q37640588 P698 Q37640588-180BD6BE-44D3-4B9E-B47E-ACA5FE89BD89 @default.
- Q37640588 P932 Q37640588-1DAC8D83-1FD7-49F0-ACAB-4188191A3D4C @default.
- Q37640588 P356 170546 @default.
- Q37640588 P698 23862169 @default.
- Q37640588 P1433 Q5030241 @default.
- Q37640588 P1476 "In a 'real-world', clinic-based community setting, sorafenib dose of 400 mg/day is as effective as standard dose of 800 mg/day in patients with advanced hepatocellular carcimona, with better tolerance and similar survival" @default.
- Q37640588 P2093 "Al Moutaz Hashim" @default.
- Q37640588 P2093 "Alan A Weiss" @default.
- Q37640588 P2093 "Alexandra Shingina" @default.
- Q37640588 P2093 "Eric M Yoshida" @default.
- Q37640588 P2093 "Fergal Donnellan" @default.
- Q37640588 P2093 "Mazhar Haque" @default.
- Q37640588 P2093 "Sharlene Gill" @default.
- Q37640588 P275 Q34179348 @default.
- Q37640588 P2860 Q27861075 @default.
- Q37640588 P2860 Q29547903 @default.
- Q37640588 P2860 Q29616230 @default.
- Q37640588 P2860 Q29617585 @default.
- Q37640588 P2860 Q35827606 @default.
- Q37640588 P2860 Q36680204 @default.
- Q37640588 P2860 Q40459361 @default.
- Q37640588 P2860 Q44599939 @default.
- Q37640588 P2860 Q46107051 @default.
- Q37640588 P2860 Q58811082 @default.
- Q37640588 P2860 Q80112177 @default.
- Q37640588 P2860 Q83484377 @default.
- Q37640588 P304 "393-396" @default.
- Q37640588 P31 Q13442814 @default.
- Q37640588 P356 "10.1155/2013/170546" @default.
- Q37640588 P407 Q1860 @default.
- Q37640588 P433 "7" @default.
- Q37640588 P478 "27" @default.
- Q37640588 P50 Q60329652 @default.
- Q37640588 P577 "2013-07-01T00:00:00Z" @default.
- Q37640588 P6216 Q50423863 @default.
- Q37640588 P698 "23862169" @default.
- Q37640588 P932 "3956016" @default.